Nexium No. 1 in Call Frequency in HP Market for 2nd Month in a Row: Rep Track Survey

According to Anterio Inc.’s Rep Track Survey, which investigates the recollections of doctors of drug detailing activities, AstraZeneca K.K.’s (AZ) proton pump inhibitor (PPI) Nexium (esomeprazole) remained No. 1 in call frequency in the hospital (HP) market (100 beds and...read more